Systematic Reviews
Copyright ©The Author(s) 2024.
World J Clin Oncol. Aug 24, 2024; 15(8): 1092-1101
Published online Aug 24, 2024. doi: 10.5306/wjco.v15.i8.1092
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1  Screening strategy for the included studies.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Meta-analyses. A: Meta-analysis of objective response; B: Disease control; C: Adverse reaction rate; D: Incidence of grade ≥ 3 adverse reactions of ripretinib in patients with gastrointestinal stromal tumor.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Sensitivity analysis. A: Sensitivity analysis of objective response; B: Disease control; C: Adverse reaction rate; D: Incidence of grade ≥ 3 adverse reactions of ripretinib in patients with gastrointestinal stromal tumor.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Begg’s funnel plots for publication bias test with pseudo 95% confidence limits. A: Objective response; B: Disease control; C: Adverse reaction rate; D: Incidence of grade ≥ 3 adverse reactions of ripretinib in patients with gastrointestinal stromal tumor.